Wanbury informs about press release

23 Aug 2024 Evaluate
Wanbury has informed that the USFDA has issued an Establishment Inspection Report (EIR) for the Company’s manufacturing facility located at MIDC Industrial Area, Patalganga, Maharashtra, India and the inspection has now been successfully closed by the USFDA. USFDA has determined that the inspection classification of this facility is ‘No Action Indicated’ (NAI) with zero 483 observations. Based on this inspection, this facility is considered to be in an acceptable state of compliance with regards to current good manufacturing practice (CGMP).

The above information is a part of company’s filings submitted to BSE.

Wanbury Share Price

242.70 3.50 (1.46%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.